Analyst Consensus ?
ConsensusHold43 ratings
Bullish1637.2%
Neutral2558.1%
Bearish24.7%
FN2 Earnings Intelligence
Universal Health Services, Inc. analyst ratings
Universal Health Services, Inc. (UHS) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$176.61Current
$121Low
$189Average
$290High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Guggenheim | Buy | Buy | Maintain | Oct 29, 2026 |
| Baird | Neutral | Neutral | Maintain | Oct 29, 2026 |
| Leerink Partners | Outperform | Outperform | Maintain | Sep 18, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Aug 20, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jul 30, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 29, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Jul 29, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 28, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 13, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jun 22, 2026 |
| UBS | Buy | Buy | Maintain | Apr 30, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Aug 4, 2025 |
| B of A Securities | Underperform | Neutral | Downgrade | Jul 16, 2025 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Feb 28, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Apr 12, 2024 |
| Mizuho | Buy | Buy | Maintain | Mar 6, 2024 |
| Citigroup | Buy | Buy | Maintain | Feb 29, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 27, 2023 |
| SVB Securities | Outperform | Market Perform | Upgrade | May 26, 2023 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Mar 1, 2023 |
| SVB Leerink | Market Perform | Market Perform | Maintain | Oct 27, 2022 |
| BMO Capital | Underperform | Market Perform | Downgrade | Jul 6, 2022 |
| Loop Capital | Hold | Hold | Maintain | Jun 17, 2022 |
| Seaport Global | Neutral | Buy | Downgrade | Feb 28, 2022 |
| Piper Sandler | Neutral | Neutral | Maintain | Feb 28, 2022 |
| Bank of America | Buy | Neutral | Upgrade | Sep 18, 2018 |
| PiperJaffray | Neutral | Overweight | Downgrade | Jan 3, 2018 |
| Leerink Swann | Outperform | Outperform | Maintain | Sep 22, 2017 |
| Raymond James | Market Perform | Outperform | Downgrade | Dec 14, 2016 |
| Avondale Partners | Market Perform | Market Outperform | Downgrade | Nov 9, 2016 |
| Wallachbeth | Hold | Buy | Downgrade | Oct 11, 2016 |
| Sterne Agee CRT | Neutral | Underperform | Upgrade | Mar 2, 2016 |
| Sterne Agee | Neutral | Underperform | Upgrade | Mar 2, 2016 |
| Standpoint Research | Buy | Hold | Upgrade | Feb 10, 2016 |
| Keybanc | Overweight | Sector Weight | Upgrade | Oct 1, 2015 |
| Janney Capital | Neutral | Neutral | Maintain | Jun 10, 2015 |
| FBR Capital | Outperform | Outperform | Maintain | Apr 28, 2014 |
| Monness Crespi Hardt | Neutral | Neutral | Maintain | Mar 31, 2014 |
| Susquehanna | Neutral | Positive | Downgrade | May 17, 2013 |
| WallachBeth Capital | Hold | Buy | Downgrade | Mar 4, 2013 |
| Imperial Capital | Outperform | Outperform | Maintain | Sep 13, 2012 |
| Jefferies | Hold | Hold | Maintain | Apr 27, 2012 |
| Auriga | Buy | Buy | Maintain | Feb 28, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $176.61. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Robert W. Baird | Michael Ha | $156 | $172.18 | -11.7% | Oct 29, 2026 |
| Guggenheim | Jason Cassorla | $201 | $172.18 | +13.8% | Oct 29, 2026 |
| RBC Capital | Ben Hendrix | $183 | $171.8 | +3.6% | Aug 3, 2026 |
| Goldman Sachs | Analyst unavailable | $190 | $168.16 | +7.6% | Jul 30, 2026 |
| UBS | Analyst unavailable | $290 | $166.22 | +64.2% | Jul 29, 2026 |
| Guggenheim | Jason Cassorla | $189 | $166.22 | +7.0% | Jul 29, 2026 |
| Robert W. Baird | Analyst unavailable | $166 | $166.22 | -6.0% | Jul 29, 2026 |
| Morgan Stanley | Craig Hettenbach | $191 | $166.22 | +8.1% | Jul 29, 2026 |
| Barclays | Analyst unavailable | $168 | $159.31 | -4.9% | Jul 28, 2026 |
| Guggenheim | Analyst unavailable | $195 | $151.16 | +10.4% | Jul 20, 2026 |
| Wells Fargo | Analyst unavailable | $166 | $155.57 | -6.0% | Jul 13, 2026 |
| Barclays | Analyst unavailable | $179 | $161.26 | +1.4% | Jul 8, 2026 |
| Wells Fargo | Analyst unavailable | $165 | $146.11 | -6.6% | Jun 1, 2026 |
| UBS | Analyst unavailable | $310 | $167.86 | +75.5% | Apr 30, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $194 | $167.51 | +9.8% | Apr 29, 2026 |
| RBC Capital | Analyst unavailable | $190 | $162.54 | +7.6% | Apr 29, 2026 |
| Guggenheim | Analyst unavailable | $211 | $162.54 | +19.5% | Apr 29, 2026 |
| Robert W. Baird | Michael Ha | $204 | $162.54 | +15.5% | Apr 29, 2026 |
| Barclays | Analyst unavailable | $238 | $179.51 | +34.8% | Apr 28, 2026 |
| Barclays | Analyst unavailable | $262 | $203.68 | +48.3% | Jan 22, 2026 |
| UBS | Analyst unavailable | $245 | $214.97 | +38.7% | Jan 7, 2026 |
| Wells Fargo | Analyst unavailable | $235 | $221.74 | +33.1% | Jan 7, 2026 |
| Guggenheim | Jason Cassorla | $274 | $239.43 | +55.1% | Dec 2, 2025 |
| Raymond James | John Ransom | $270 | $217.01 | +52.9% | Nov 3, 2025 |
| UBS | Analyst unavailable | $231 | $225.3 | +30.8% | Oct 30, 2025 |
| RBC Capital | Ben Hendrix | $231 | $223.61 | +30.8% | Oct 30, 2025 |
| UBS | Analyst unavailable | $302 | $219.32 | +71.0% | Oct 29, 2025 |
| Guggenheim | Jason Cassorla | $253 | $219.32 | +43.3% | Oct 29, 2025 |
| Morgan Stanley | Craig Hettenbach | $233 | $219.32 | +31.9% | Oct 29, 2025 |
| Barclays | Analyst unavailable | $263 | $214.03 | +48.9% | Oct 28, 2025 |
| Mizuho Securities | Ann Hynes | $242 | $214.03 | +37.0% | Oct 28, 2025 |
| Goldman Sachs | Analyst unavailable | $219 | $197.76 | +24.0% | Oct 14, 2025 |
| Wells Fargo | Analyst unavailable | $249 | $209.11 | +41.0% | Oct 7, 2025 |
| Robert W. Baird | Michael Ha | $203 | $177.91 | +14.9% | Aug 14, 2025 |
| UBS | Analyst unavailable | $227 | $165.44 | +28.5% | Jul 30, 2025 |
| Morgan Stanley | Analyst unavailable | $200 | $184.46 | +13.2% | Mar 26, 2025 |
| Robert W. Baird | Michael Ha | $274 | $236.47 | +55.1% | Sep 4, 2024 |
| Raymond James | Sarah James | $219 | $204.99 | +24.0% | Jul 26, 2024 |
| Barclays | Andrew Mok | $256 | $210.68 | +45.0% | Jul 26, 2024 |
| Robert W. Baird | Michael Ha | $236 | $187.7 | +33.6% | Jun 26, 2024 |
| HSBC | Sidharth Sahoo | $290 | $94 | +64.2% | Jun 5, 2024 |
| UBS | AJ Rice | $226 | $177.7 | +28.0% | May 20, 2024 |
| RBC Capital | Frank Morgan | $189 | $169.15 | +7.0% | May 7, 2024 |
| Deutsche Bank | Pito Chickering | $203 | $168.4 | +14.9% | Apr 12, 2024 |
| Stephens | Scott Fidel | $185 | $182.46 | +4.8% | Apr 1, 2024 |
| Barclays | Steven Valiquette | $142 | $140.7 | -19.6% | Apr 25, 2023 |
| Barclays | Analyst unavailable | $132 | $152.21 | -25.3% | Jan 9, 2023 |
| Wells Fargo | Stephen Baxter | $154 | $142.04 | -12.8% | Jan 3, 2023 |
| Goldman Sachs | Analyst unavailable | $110 | $102.03 | -37.7% | Jul 12, 2022 |
| Credit Suisse | Analyst unavailable | $141 | $102.24 | -20.2% | Jul 1, 2022 |
| Mizuho Securities | Analyst unavailable | $121 | $102.07 | -31.5% | Jul 1, 2022 |
| Mizuho Securities | Analyst unavailable | $153 | $124.98 | -13.4% | May 3, 2022 |
| Wells Fargo | Analyst unavailable | $118 | $124.16 | -33.2% | Apr 28, 2022 |
| Stephens | Analyst unavailable | $135 | $124.32 | -23.6% | Apr 27, 2022 |
| Credit Suisse | Analyst unavailable | $158 | $125.32 | -10.5% | Apr 27, 2022 |
| RBC Capital | Analyst unavailable | $130 | $125.32 | -26.4% | Apr 27, 2022 |
| Mizuho Securities | Ann Hynes | $145 | $69.38 | -17.9% | Apr 26, 2022 |
| Goldman Sachs | Jamie Perse | $135 | $128.04 | -23.6% | Nov 9, 2021 |
| Stephens | Scott Fidel | $142 | $124.54 | -19.6% | Oct 27, 2021 |
| BMO Capital | Matthew Borsch | $145 | $124.54 | -17.9% | Oct 27, 2021 |
| Bank of America Securities | Kevin Fischbeck | $153 | $125.79 | -13.4% | Oct 26, 2021 |
| Credit Suisse | A.J. Rice | $181 | $158.43 | +2.5% | Jul 27, 2021 |
| Wolfe Research | Justin Lake | $171 | $151.2 | -3.2% | Jun 21, 2021 |
Track every rating change on UHS the moment it posts. Free to start.
Start freeGet the UHS recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.